Forte Biosciences Inc (NASDAQ:FBRX) currently has a daily average trading volume of 467.19K but it saw 1263127 shares traded in last market. With a market cap of 22.86M USD, the company’s current market price of $15.64 came rising about 15.42 while comparing to the previous closing price of $13.55. In past 52 weeks, the stock remained buoying in the range of price level as high as $21.25 and as low as $4.11. In the recent trading on the day, stock has struck highest price mark of $10.1101 while lowest mark touched by it was $15.93.
Taking a look at 20-day trading activity of Forte Biosciences Inc (FBRX) gives us an average price of $6.01, while its current price level is -26.40% below from 52-week high level whereas it is 280.54% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.75 while that of 200 days or SMA-200 reads an average of $12.42. A closer look into the stock’s movement over the week reveals that its volatility is standing at 39.44% during that period while stretching the period over a month that decreases to 15.30%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 92.84 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Ladenburg Thalmann which upgraded the stock as “Buy” in its note to investors issued on April 08, 2024, recommending a price target of $2.75 for it. Chardan Capital Markets upgraded its recommendation for the stock as a “Buy” from “Sell” on September 20, 2021 while assigning a price target range of $4-$3.50. Truist issued its recommendations for the stock as it downgraded the price target for the stock is $4.
Over the week, FBRX’s stock price is moving 180.29% up while it is 223.81% when we observe its performance for the past one month. Year-to-date it is -23.87% down and over the past year, the stock is showing an upside performance of 44.65%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1 beat the consensus estimate of -7 for the same. The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of -2.74 while estimate for next year EPS is -14.81.
Currently, Forte Biosciences Inc’s total number of outstanding shares is 1.45M with 10.94% of that held by the insiders while 54.05% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -365.10% and return on equity (ROE) at -137.40%. Stock’s beta reads 0.34. Stock has a price to book (P/B) ratio of 2.44. Its return on asset (ROA) is -103.90% on average.
